B-cell-activating factor (BAFF) and platelet-activating factor (PAF) in pregnancies complicated by maternal obesity and diabetes: a preliminary study

References

• American College of Obstetricians and Gynecologists. ACOG Committee opinion no. 549: obesity in pregnancy. Obstet Gynecol. 2013;121(1):213–217.
   PubMedGoogle Scholar
• Pantham P, Aye ILMH, Powell TL. Inflammation in maternal obesity and gestational diabetes mellitus. Placenta. 2015;36(7):709–715. doi: 10.1016/j.placenta.2015.04.006.
   PubMed Web of Science ®Google Scholar
• Renault KM, Norgaard K, Nilas L, et al. The treatment of obese pregnant women (TOP) study: a randomized controlled trial of the effect of physical activity intervention assessed by pedometer with or without dietary intervention in obese pregnant women. Am J Obstet Gynecol. 2014;210(2):134.e1–134.e9. doi: 10.1016/j.ajog.2013.09.029.
   PubMed Web of Science ®Google Scholar
• World Health Organization. WHO report. 2022. Available from: http://www.who.int/mediacentre/factsheets/fs311/en/
   Google Scholar
• Poston L, Caleyachetty R, Cnattingius R, et al. Preconceptional and maternal obesity: epidemiology and health consequences. Lancet Diabetes Endocrinol. 2016;4(12):1025–1036. doi: 10.1016/S2213-8587(16)30217-0.
   PubMed Web of Science ®Google Scholar
• Neri C, Di Cesare C, Labianca A, et al. Obesity in pregnancy as a model to identify women at risk for later metabolic syndrome. Gynecol Endocrinol. 2018;34(1):28–31. doi: 10.1080/09513590.2017.1342792.
   PubMed Web of Science ®Google Scholar
• Jones CW. Gestational diabetes and its impact on the neonate. Neonatal Netw. 2001;20(6):17–23. doi: 10.1891/0730-0832.20.6.17.
   PubMedGoogle Scholar
• Hales CN, Barker DJ. Type 2 (non-insulin-dependent) diabetes mellitus: the thrifty phenotype hypothesis. 1992. Int J Epidemiol. 2013;42(5):1215–1222. doi: 10.1093/ije/dyt133.
   PubMed Web of Science ®Google Scholar
• Krakowiak P, Walker CK, Bremer AA, et al. Maternal metabolic conditions and risk for autism and other neurodevelopmental disorders. Pediatrics. 2012;129(5):e1121–e1128. doi: 10.1542/peds.2011-2583.
   PubMed Web of Science ®Google Scholar
• Huda SS, Brodie LE, Sattar N. Obesity in pregnancy: prevalence and metabolic consequences. Semin Fetal Neonatal Med. 2010;15(2):70–76. doi: 10.1016/j.siny.2009.09.006.
   PubMed Web of Science ®Google Scholar
• Taddei S, Ghiadoni L, Salvetti G, et al. Obesity and endothelial dysfunction. G Ital Cardiol (Rome). 2006;7(11):715–723.
   PubMedGoogle Scholar
• Gregor MF, Hotamisligil GS. Inflammatory mechanisms in obesity. Annu Rev Immunol. 2011;29(1):415–445. doi: 10.1146/annurev-immunol-031210-101322.
   PubMedGoogle Scholar
• Aye IL, Lager S, Ramirez VI, et al. Increasing maternal body mass index is associated with systemic inflammation in the mother and the activation of distinct placental inflammatory pathways. Biol Reprod. 2014;90(6):129.
   PubMed Web of Science ®Google Scholar
• Kleiblova P, Dostalova I, Bartlova M, et al. Expression of adipokines and estrogen receptors in adipose tissue and placenta of patients with gestational diabetes mellitus. Mol Cell Endocrinol. 2010;314(1):150–156. doi: 10.1016/j.mce.2009.08.002.
   PubMed Web of Science ®Google Scholar
• Hauguel-de Mouzon S, Guerre-Millo M. The placenta cytokine network and inflammatory signals. Placenta. 2006;27(8):794–798.
   PubMed Web of Science ®Google Scholar
• Jansson N, Rosario FJ, Gaccioli F, et al. Activation of placental mTOR signaling and amino acid transporters in obese women giving birth to large babies. J Clin Endocrinol Metab. 2013;98(1):105–113. doi: 10.1210/jc.2012-2667.
   PubMed Web of Science ®Google Scholar
• Jansson T, Ekstrand Y, Bjorn C, et al. Alterations in the activity of placental amino acid transporters in pregnancies complicated by diabetes. Diabetes. 2002;51(7):2214–2219. doi: 10.2337/diabetes.51.7.2214.
   PubMed Web of Science ®Google Scholar
• Jones HN, Jansson T, Powell TL. IL-6 stimulates system A amino acid transporter activity in trophoblast cells through STAT3 and increased expression of SNAT2. Am J Physiol Cell Physiol. 2009;297(5):C1228–C1235. doi: 10.1152/ajpcell.00195.2009.
   PubMed Web of Science ®Google Scholar
• Jones HN, Woollett LA, Barbour N, et al. High-fat diet before and during pregnancy causes marked up-regulation of placental nutrient transport and fetal overgrowth in C57/BL6 mice. FASEB J. 2009;23(1):271–278. doi: 10.1096/fj.08-116889.
   PubMed Web of Science ®Google Scholar
• Jarvie E, Hauguel-de-Mouzon S, Nelson SM, et al. Lipotoxicity in obese pregnancy and its potential role in adverse pregnancy outcome and obesity in the offspring. Clin Sci. 2010;119(3):123–129. doi: 10.1042/CS20090640.
   PubMed Web of Science ®Google Scholar
• Piuri G, Basello K, Rossi G, et al. Methylglyoxal, glycated albumin, PAF, and TNF-α: possible inflammatory and metabolic biomarkers for management of gestational diabetes. Nutrient. 2020;12(2):479. doi: 10.3390/nu12020479.
   PubMed Web of Science ®Google Scholar
• Cappelletti M, Tognon E, Vona L, et al. Specific serum IgG and symptom reduction with a personalized, unrestricted-calorie diet of six weeks in irritable bowel syndrome (IBS). Nutr Metab. 2020;17(1):101. doi: 10.1186/s12986-020-00528-x.
   Google Scholar
• Speciani AF, Piuri G. Measuring biomarkers for an innovative personal food profile. J Am Coll Nutr. 2015;34(Suppl 1):34–38. doi: 10.1080/07315724.2015.1080109.
   PubMedGoogle Scholar
• Schneider P, MacKay F, Steiner V, et al. BAFF, a novel ligand of the tumor necrosis factor family, stimulates B cell growth. J Exp Med. 1999;189(11):1747–1756. doi: 10.1084/jem.189.11.1747.
   PubMed Web of Science ®Google Scholar
• Sutherland APR, Mackay F, Mackay CR, et al. Targeting BAFF: immunomodulation for autoimmune diseases and lymphomas. Pharmacol Ther. 2006;112(3):774–786. doi: 10.1016/j.pharmthera.2006.06.002.
   PubMed Web of Science ®Google Scholar
• Cheema GS, Roschke V, Hilbert DM, et al. Elevated serum B-lymphocyte stimulator levels in patients with systemic immune based rheumatic diseases. Arthritis Rheum. 2001;44(6):1313–1319. doi: 10.1002/1529-0131(200106)44:6<1313::AID-ART223>3.0.CO;2-S.
   PubMed Web of Science ®Google Scholar
• Ritterhouse LL, Crowe SR, Niewold TB, et al. B lymphocyte stimulator levels in systemic lupus erythematosus: higher circulating levels in African American patients and increased production after influenza vaccination in patients with low baseline levels. Arthritis Rheum. 2011;63(12):3931–3941. doi: 10.1002/art.30598.
   PubMedGoogle Scholar
• Fabris M, Visentini D, De Re V, et al. Elevated b cell-activating factor of the tumour necrosis factor family in coeliac disease. Scand J Gastroenterol. 2007;42(12):1434–1439. doi: 10.1080/00365520701452225.
   PubMed Web of Science ®Google Scholar
• Steri M, Orrù V, Idda ML, et al. Overexpression of the cytokine BAFF and autoimmunity risk. N Engl J Med. 2017;376(17):1615–1626. doi: 10.1056/NEJMoa1610528.
   PubMed Web of Science ®Google Scholar
• Kim YH, Choi BH, Cheon HG, et al. B cell activation factor (BAFF) is a novel adipokine that links obesity and inflammation. Exp Mol Med. 2009;41(3):208–216. PMID: 19293640. PMC2679246. doi: 10.3858/emm.2009.41.3.024.
   PubMed Web of Science ®Google Scholar
• Upton JEM, Grunebaum E, Sussman G, et al. Platelet activating factor PAF: a mediator of inflammation. Biofactors. 2022;48(6):1189–1202. PMID 36029481 doi: 10.1002/biof.1883.
   PubMed Web of Science ®Google Scholar
• Ashraf MA, Nookala V. Biochemistry of platelet activating factor. Treasure Island (FL): StatPearls Publishing; 2022.
   Google Scholar
• Yamaguchi M, Matsui M, Higa R, et al. A platelet-activating factor (PAF) receptor deficiency exacerbates diet-induced obesity but PAF/PAF receptor signaling does not contribute to the development of obesity-induced chronic inflammation. Biochem Pharmacol. 2015;93(4):482–495. doi: 10.1016/j.bcp.2014.12.022.
   PubMed Web of Science ®Google Scholar
• Filgueiras LR, Koga MM, Quaresma PG, et al. PAFR in adipose tissue macrophages is associated with anti-inflammatory phenotype and metabolic homeostasis. Clin Sci. 2016;130(8):601–612. doi: 10.1042/CS20150538.
   Web of Science ®Google Scholar
• Kang SA, Keener AB, Jones SZ, et al. IgG-immune complexes promote B cell memory by inducing BAFF. J Immunol. 2016;196(1):196–206. doi: 10.4049/jimmunol.1402527.
   PubMed Web of Science ®Google Scholar
• Gao Q, He G-L, Zhang L, et al. Activity and distribution of plasma platelet-activating factor acetylhydrolase in women with gestational diabetes mellitus and their neonates. Diabetes Metab Res Rev. 2016;32(6):634–642. doi: 10.1002/dmrr.2782.
   PubMed Web of Science ®Google Scholar
• Derbent A, Kargili A, Koca C, et al. Serum platelet-activating factor acetylhydrolase activity: relationship with metabolic syndrome in women with history of gestational diabetes mellitus. Gynecol Endocrinol. 2011;27(2):128–133. doi: 10.3109/09513590.2010.487612.
   PubMed Web of Science ®Google Scholar
• Mackay F, Schneider P. Cracking the BAFF code. Nat Rev Immunol. 2009;9(7):491–502. PMID: 19521398 doi: 10.1038/nri2572.
   PubMed Web of Science ®Google Scholar
• Liu S, Miao J-J, Zhou X, et al. High levels of thyroid hormones promote recurrence of Graves’ disease via overexpression of B-cell-activating factor. J Clin Lab Anal. 2022;36(10):e24701. PMID: 36097969 PMCID: PMC9550970 doi: 10.1002/jcla.24701.
   PubMed Web of Science ®Google Scholar
• Lin JD, Wang YH, Fang WF, et al. Serum BAFF and thyroid autoantibodies in autoimmune thyroid disease. Clin Chim Acta. 2016;462:96–102. PMID: 27616625 doi: 10.1016/j.cca.2016.09.004.
   PubMed Web of Science ®Google Scholar
• Lane LC, Allinson KR, Campbell K, et al. Analysis of BAFF gene polymorphisms in UK graves’ disease patients. Clin Endocrinol. 2019;90(1):170–174. PMID: 30281845 doi: 10.1111/cen.13872.
   PubMed Web of Science ®Google Scholar
• Vannucchi G, Covelli D, Currò N, et al. Serum BAFF concentrations in patients with Graves’ disease and orbitopathy before and after immunosuppressive therapy. J Clin Endocrinol Metab. 2012;97(5):E755–E759. PMID: 22399512. doi: 10.1210/jc.2011-2614.
   PubMed Web of Science ®Google Scholar
• Campi I, Tosi D, Rossi S, et al. B cell activating factor (BAFF) and BAFF receptor expression in autoimmune and nonautoimmune thyroid diseases. Thyroid. 2015;25(9):1043–1049. PMID: 26214745 doi: 10.1089/thy.2015.0029.
   PubMed Web of Science ®Google Scholar
• Arslan Lied G, Lillestøl K, Valeur J, et al. Intestinal B cell-activating factor: an indicator of non-IgE-mediated hypersensitivity reactions to food? Aliment Pharmacol Ther. 2010;32(1):66–73. PMID20353497 doi: 10.1111/j.1365-2036.2010.04314.x.
   PubMed Web of Science ®Google Scholar
• Gu L, Yang J, Gong Y, et al. Lower free thyroid hormone levels are associated with high blood glucose and insulin resistance; these normalize with metabolic improvement of type 2 diabetes. J Diabetes. 2021;13(4):318–329. PMID: 32981234 doi: 10.1111/1753-0407.13118.
   PubMed Web of Science ®Google Scholar